Bookmark

Add to MyYahoo RSS

OrthoClinical Diagnostics News

News on OrthoClinical Diagnostics (Ticker: JNJ) continually updated from thousands of sources around the net.

2 hrs ago | Barron's

Target Price Increases Abound For J&J, But Stock Slips

Johnson & Johnson was giving up some of Tuesday's gains , although analysts were largely upbeat about the company's better-than-expected first-quarter earnings report, as evidenced by a flurry of target price increases.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

6 hrs ago | Canadian Business Magazine

Forgetting to take your medicine? Smartphone apps help patients remember and track doses

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

11 hrs ago | Seeking Alpha

Why Johnson & Johnson Can Be Prescribed For Most Investors

Background : Johnson & Johnson may be the bluest of all U.S. blue chip stocks now.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Aria Systems, VisionCare Ophthalmic Technologies, Startups

15 hrs ago | Drug Researcher

TransCelerate recognizes training programs from Icon, Synteract

Industry group TransCelerate Biopharma has certified that training programs from CROs Icon and SynteractHCR meet minimum criteria for ICH's good clinical practice training.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Tue Apr 15, 2014

BayStreet.ca

Twitter Buys Gnip to Monetize Data; Johnson & Johnson Beats...

Shares of Twitter closed up 11.38% on Tuesday with about 24.2 million shares traded.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

The Washington Post

J&J Pharmaceutical Success Drives Increase in 2014 Forecast

Johnson & Johnson, the world's biggest maker of health-care products, beat expectations and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

WBIR-TV Knoxville

Stocks close higher as Ukraine crisis sparks volatility

Stocks gave up early gains and were trading lower in late morning trading Tuesday.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

The New Zealand Herald

Wall St up on Coca-Cola fizz

Wall Street advanced overnight, spearheaded by gains in shares of Coca-Cola and Johnson & Johnson after both companies reported quarterly results that surpassed expectations, bolstering confidence about the outlook.

Comment?

Related Topix: Beverages, CocaCola, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

SchaeffersResearch.com

Midday Market Stats: Dow Jones Industrial Average Stumbles on Mixed Economic News

The Dow Jones Industrial Average was earlier trying to extend Monday's positive momentum, and helping toward this goal were Dow components The Coca-Cola Company and Johnson & Johnson , which remain in the black on well-received earnings reports.

Comment?

Related Topix: The Dow Company, Beverages, CocaCola, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

The Globe and Mail

Johnson & Johnson tops forecasts, helped by new medicines

In this Jan. 24, 2011 photo, Johnson & Johnson Band-Aid products are displayed, in Montpelier, Vt.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Mon Apr 14, 2014

TheStreet.com

Investing Ahead of Earnings: Johnson & Johnson and Coca Cola

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Investopedia

Hedge Funds Love These 3 Pharma Stocks

In 2012, the star performer among sectors was the financial sector. In 2013, it was consumer discretionary stocks.

Comment?

Related Topix: Financial Markets, Warren Buffett, Healthcare Law, Law, Medicaid, Health, Biotech, Johnson and Johnson, Medicine, Medical Equipment, Healthcare Industry

Limerick Today

420 new jobs for Limerick in a 80m investment

Dan Wildman, president of Ethicon Biosurgery, with Ministers Michael Noonan and Richard Bruton at today's jobs announcement [Picture: Michael Cowhey] MORE than 400 jobs are to be created in Limerick following the announcement of a 80m investment by Ethicon Biosurgery Ireland.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls, Medical Equipment

Sun Apr 13, 2014

The Daily Record

Campaigners renew calls for end to mesh implant operations after US court says device is defective

AMERICAN victim wins A 750,000 compensation from drugs giant Johnson & Johnson in a case that could have a big impact on the civil actions for damages launched by 400 Scottish women against mesh makers and NHS Scotland.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Fri Apr 11, 2014

Reuters

J&J says halting development of Botox rival

Johnson & Johnson said on Friday it was ending its efforts to bring to market a rival drug to Allergan Inc's popular Botox anti-wrinkle treatment.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Medical Equipment

The Motley Fool

Here's What's Behind Puma's Crash

Alan Auerbach, the former CEO of Cougar Biotechnology -- the company that developed Johnson & Johnson 's widely successful Zytiga prostate cancer drug -- hopes he has another blockbuster potential drug on his hands at Puma Biotechnology Xeloda head to head against GlaxoSmithKline 's Tykerb and Xeloda.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Seeking Alpha

Earnings Preview: Johnson & Johnson Q1 2014

Johnson & Johnson is slated to report 1Q 2014 earnings before the bell on Tuesday, April 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Thu Apr 10, 2014

Boston.com

Law firm Mintz Levin expands intellectual property practice

William C. Geary III, Lisa Adams, and Christina Sperry have joined as members of Mintz Levin's Boston office, the firm said in a Thursday press release .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

The Huffington Post

Nigel Barker: Learning From Strong Women

This post is part of the Global Moms Relay . Every time you share this post, Johnson & Johnson will donate $1 to help improve the health and well-being of moms and kids worldwide through MAMA , Shot@Life , and Girl Up .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

Tue Apr 08, 2014

Law.com

Janssen Settles 76 Topamax Cases in Philadelphia

Johnson & Johnson subsidiary Janssen Pharmaceuticals has settled 76 cases in which plaintiffs alleged that the anti-seizure drug Topamax, taken during pregnancy, caused birth defects, according to a Philadelphia court order.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, Medical Equipment

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••